Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.96 -0.04 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $44.38 | |||
| Open | $8.14 | 52 Week Low | $24.47 | |||
| Day High | $8.26 | P/E | 398.00 | |||
| Day Low | $7.95 | EPS | $0.02 | |||
| Volume | 180,143 | |||||
